FIELD: medicine.
SUBSTANCE: present group of inventions concerns treating multiple sclerosis in experiment. That is a therapeutic agent representing an activated potentiated antibodies to brain-specific protein S-100.
EFFECT: injection drug experimental animals removed time of occurrence of signs of autoimmune encephalomyelitis and reduced severity of clinical manifestations of the disease.
9 cl, 4 dwg, 2 ex
